ChannelLife US - Industry insider news for technology resellers
United States
Natasha Toohey named Chief Executive Officer of I-MED

Natasha Toohey named Chief Executive Officer of I-MED

Sun, 15th Nov 2026 (Today)
Mara Sugue
MARA SUGUE News Editor

Jardine Matheson and I-MED Radiology Network have appointed Natasha Toohey as Chief Executive Officer of I-MED, with her start date to follow Jardine Matheson's acquisition of the diagnostic imaging provider.

Toohey is currently Chief Operating Officer at Epworth HealthCare, where she oversees a hospital network handling about 240,000 admissions and 150,000 procedures a year. Since joining Epworth in 2022, she has managed a workforce of more than 8,000 employees and 4,000 visiting medical officers.

Her appointment comes as Jardine Matheson integrates I-MED, which it acquired in October as its first major investment since shifting to an investment company structure in 2025. I-MED operates across Australia, New Zealand and the United States and has built its business around relationships with patients, clinicians and hospital partners.

Toohey will begin engaging with I-MED colleagues in February before formally starting in March, in a transition period designed to support the handover.

Before joining Epworth, she spent more than a decade at Western Health, including four years as Executive Director of Operations. In that role, she oversaw multi-site healthcare operations and worked on service expansion, technology and capital programs.

Her career began in physiotherapy before she moved into healthcare management and operations. She holds a Master of Public Health from Monash University, a Bachelor of Physiotherapy from the University of Melbourne, and is a graduate of the Australian Institute of Company Directors.

I-MED is one of the larger diagnostic imaging providers in Australia and New Zealand. It carries out more than seven million patient procedures each year through a network of clinics and hospitals, with more than 500 radiologists and services spanning X-ray, CT, MRI, ultrasound, mammography, nuclear medicine and PET.

The appointment ends the search for a permanent leader after a period under acting Chief Executive Officer Clare Battellino, who will continue to provide leadership and counsel to the business.

In comments on the appointment, the incoming Chief Executive Officer pointed to the scale of the network and its role in patient care.

"I am delighted to be joining I-MED at an exciting time in its development. I-MED is a leader in its field, with an outstanding clinical reputation and an important role in patient care across Australia, New Zealand and the United States. I look forward to working with I-MED's team of doctors and staff, and to building on the company's strong foundations as I-MED continues to expand its diagnostic imaging services and strengthen its contribution to improving healthcare outcomes for patients and referring clinicians," said Natasha Toohey, incoming Chief Executive Officer of I-MED.

Jardine Matheson Chief Executive Officer Lincoln Pan said the group viewed the appointment through the lens of long-term ownership.

"We are delighted to welcome Natasha to I-MED. Natasha brings extensive experience in healthcare delivery, with a strong record of driving growth, organisational excellence, operational improvement and transformation. She is recognised for her collaborative leadership style with medical practitioners and her teams, and for her commitment to high-quality and safe patient care. As shareholder, our objective for I-MED at Jardines is to pursue a long-term strategy that builds a bigger and better business, and Natasha's successful leadership track record in large, complex medical systems will further enhance the terrific company I-MED already is," said Pan.

He also acknowledged the acting Chief Executive Officer's role during the transition.

"Jardines and the Board of I-MED would like to thank Clare Battellino for her continued leadership as acting Chief Executive Officer. She has made important contributions to I-MED over many years, including during this transitional period, and the Board looks forward to Clare's ongoing counsel and leadership for I-MED," Pan said.

I-MED Chair George Savvides linked the appointment to the company's ties with hospitals, specialists and referring doctors.

"Natasha is well placed to lead I-MED through its next phase of development while maintaining the high standards of service and care that underpin the trust I-MED has built with patients, clinicians and partners. I-MED's partnerships with hospitals, medical specialists and medical practitioners are paramount to our future success, and Natasha's deep health sector experience building collaborative, sustainable partnerships will lift I-MED's capabilities to serve our referral and hospital partners and, importantly, attract and retain the best radiologists and clinical teams to I-MED," said Savvides.